Real-world outcomes in patients with malignancy and moderate-to-severe psoriasis treated with guselkumab.
Gracia Cazaña T, Riera Monroig J, Izu R, Yanguas I, Lorda Espés M, Sánchez Salas MP, García Gil MF, Navarro Bielsa A, Aldea Manrique B, Almenara Blasco M, García-Latasa de Araníbar FJ, Fuentelsaz V, Morales Callaghan A, Ara-Martín M.
Gracia Cazaña T, et al. Among authors: garcia gil mf.
JAAD Int. 2024 Apr 7;16:66-71. doi: 10.1016/j.jdin.2024.02.019. eCollection 2024 Sep.
JAAD Int. 2024.
PMID: 38774344
Free PMC article.